AU Patent

AU1678900A — A novel liposomal formulation useful in treatment of cancer and other proliferation diseases

Assigned to All India Institute of Medical Sciences AIIMS · Expires 2000-03-06 · 26y expired

What this patent protects

Patent listed against Camptosar.

Drugs covered by this patent

Patent Metadata

Patent number
AU1678900A
Jurisdiction
AU
Classification
—
Expires
2000-03-06
Drug substance claim
No
Drug product claim
No
Assignee
All India Institute of Medical Sciences AIIMS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.